Search

Establishing a genomic reference for Australian Aboriginal populations

The aim of this study was to investigate the extent to which factors previously documented as buffering the impact of high-risk family environments on...

A considerable health disparity exists between Aboriginal and non-Aboriginal Australians, including a higher incidence and severity of cardiovascular and...

This is the third fact sheet regarding the Aboriginal and Torres Strait Islander Suicide Prevention Evaluation Project.

Consideration of suicide among Aboriginal and Torres Strait Islander peoples must be situated within a context that recognises the impact of racism...

Human genetic research promises to deliver a range of health benefits to the population. Here we consider how the different levels of Indigenous research...

Statistical time series derived from administrative data sets form key indicators in measuring progress.

The pattern of association between socioeconomic factors and health outcomes has primarily depicted better health for those who are higher in the social...

Vitamin D deficiency (serum 25-hydroxyvitamin D (25(OH)D) concentration <50 nmol/l) is recognised as a public health problem globally. The present study details the prevalence and predictors of vitamin D deficiency in a nationally representative sample (n 3250) of Australian Aboriginal and Torres Strait Islander adults aged ≥18 years. We used data from the 2012-2013 Australian Aboriginal and Torres Strait Islander Health Survey (AATSIHS). Serum 25(OH)D concentrations were measured by liquid chromatography-tandem MS.

Expanded carrier screening (ECS) for recessive monogenic diseases requires prior knowledge of genomic variation, including DNA variants that cause disease. The composition of pathogenic variants differs greatly among human populations, but historically, research about monogenic diseases has focused mainly on people with European ancestry. By comparison, less is known about pathogenic DNA variants in people from other pa